ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Tadalafil UKSC decision – evolution of the multi-factorial approach
July 05, 2019Tadalafil UKSC decision – evolution of the multi-factorial approach. -
Bristol-Myers' rumored activists 'haven't made a decision' on the company yet
February 24, 2019Activist hedge fund Starboard Value is “certainly interested in the story at Bristol-Myers,” according to its leader. But that doesn’t mean it’s getting involved. -
US court affirms decision to permit Fresenius to withdraw from deal to buy Akorn
December 10, 2018The Delaware Supreme Court on Friday upheld a lower court ruling permitting Fresenius Kabi to terminate its agreement to acquire Akorn for more than $4 billion. Shares in the latter drugmaker were down as much as 37 percent on the news.
Pharma Sources Insight January 2025
